Prevalence of Latent Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A South-East London Cohort Study

被引：0
|
作者：
Paine, Gabriel Wisenfeld [1 ]
Cox, Rosie [1 ]
Evans, Rosa [1 ]
Hudson, Jake [1 ]
Baker, Lucy [1 ]
Simpson, Thomas [1 ]
机构：
[1] Lewisham & Greenwich NHS Trust, Univ Hosp Lewisham, London, England
来源：
LUNG CANCER | 2025年 / 200卷
关键词：
D O I：
10.1016/j.lungcan.2025.108243
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
133
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Clostridioides difficile infection in cancer patients receiving immune checkpoint inhibitors
    Vasavada, Shaleen
    Panneerselvam, Kavea
    Amin, Rajan
    Varatharajalu, Krishnavathana
    Okhuysen, Pablo C.
    Oliva, Isabella C. Glitza
    Wang, Jianbo
    Grivas, Petros
    Thomas, Anusha S.
    Wang, Yinghong
    ANNALS OF GASTROENTEROLOGY, 2022, 35 (04): : 393 - +
  • [32] Cytomegalovirus infection among patients with cancer receiving immune checkpoint inhibitors
    Panneerselvam, Kavea
    Szafron, David
    Amin, Rajan N.
    Wei, Dongguang
    Tan, Dongfeng
    Altan, Mehmet
    Okhuysen, Pablo C.
    Shatila, Malek
    Raju, Gottumukkala Subba
    Thomas, Anusha S.
    Wang, Yinghong
    ANNALS OF GASTROENTEROLOGY, 2022, 35 (05): : 522 - +
  • [33] Features of Microscopic Colitis in Cancer Patients Receiving Immune Checkpoint Inhibitors
    Choi, Kati
    Abu-Sbeih, Hamzah
    Samdani, Rashmi
    Raju, Gottumukkala
    Richards, David
    Stroehlein, John
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S67 - S67
  • [34] PREVALENCE OF LATENT TUBERCULOSIS INFECTION AMONG PATIENTS WITH LUNG CANCER
    Kamimaki, Chisato
    Kobayashi, Nobuaki
    Hirata, Momo
    Kubo, Sousuke
    Katakura, Seigo
    Teranishi, Shuhei
    Manabe, Saki
    Yamamoto, Masaki
    Kudo, Makoto
    Kaneko, Takeshi
    RESPIROLOGY, 2019, 24 : 58 - 58
  • [35] Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors
    Chen, Xiuqiong
    Li, Zhaona
    Zhou, Jing
    Wei, Qianhui
    Wang, Xinyue
    Jiang, Richeng
    PEERJ, 2022, 10
  • [36] Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors
    Catalano, Martina
    Fancelli, Sara
    Caliman, Enrico
    Mazzoni, Francesca
    Michelet, Marta Gatta
    Mancini, Silvia
    Manneschi, Clara
    Shabani, Sonia
    Napolitano, Brunella
    Pillozzi, Serena
    Antonuzzo, Lorenzo
    Roviello, Giandomenico
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [37] Survival outcomes of patients with nonsmall cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors
    Baek, Yeon-Hee
    Kang, Eun Joo
    Hong, Soojung
    Park, Sohee
    Kim, Ju Hwan
    Shin, Ju-Young
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (08) : 1291 - 1300
  • [38] Antibiotic therapy and metabolism in lung cancer patients receiving checkpoint inhibitors
    Castello, Angelo
    Rossi, Sabrina
    Toschi, Luca
    Lopci, Egesta
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [39] A Retrospective Cohort Study of Multiple Immune-Related Adverse Events and Clinical Outcomes Among Patients With Cancer Receiving Immune Checkpoint Inhibitors
    Hata, Hiroki
    Matsumura, Chikako
    Chisaki, Yugo
    Nishioka, Kae
    Tokuda, Misaki
    Miyagi, Kazuyo
    Suizu, Tomoki
    Yano, Yoshitaka
    CANCER CONTROL, 2022, 29
  • [40] Delayed and posttreatment immune toxicities in patients with breast cancer receiving immune checkpoint inhibitors
    Jacob, Saya
    Fisch, Samantha
    Face, Carolyn
    Huppert, Laura
    Quandt, Zoe
    Quintal, Laura
    Melisko, Michelle
    Majure, Melanie
    Chien, Jo
    Blaes, Anne
    Rugo, Hope
    CANCER RESEARCH, 2024, 84 (09)
12345